Calcium gluconate 10%
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Calcium gluconate 10% and local guidelines before prescribing.
Mechanism
Calcium salt that stabilises cardiac myocyte membranes against hyperkalaemic depolarisation.
Uses
Hyperkalaemia with ECG changes, hypocalcaemia, calcium channel blocker or magnesium toxicity.
Dosing
Quick reference (Makindo topics site)
| Main use | Adult dose | Key pearl / caution |
|---|---|---|
| Hyperkalaemia with ECG changes | 30 mL IV over 2–5 min | Protects the myocardium only; does not lower potassium. |
Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.
Check: the MHRA national patient safety alert on calcium gluconate in severe hyperkalaemia advises 30 mL of 10% (6.8 mmol) given over 10 minutes, repeated if ECG changes persist at 5–10 minutes. The 2–5 minute rate above is as written on the topics site and may need updating.
This drug is not covered by a dedicated section of the textbook chapters.
Side effects
Hypotension, bradycardia, arrhythmias, tissue necrosis if extravasated, peripheral vein irritation.
Interactions
Digoxin toxicity risk with IV calcium.
Contraindications and cautions
Hypercalcaemia, digoxin toxicity (caution), with ceftriaxone in neonates
Monitoring
ECG during IV use, calcium
Pregnancy and breastfeeding
Use as needed
Renal and hepatic impairment
Monitor in renal impairment
Overdose and reversal
Stop infusion; supportive
Special advice
Give with ECG monitoring; does not lower potassium, so also give insulin-dextrose; use the protocol-stated volume and rate (MHRA alert).